{
  "context": {
    "rules": [
      "Rule1: Either the company produces the compound or the product is safe for human use.",
      "Rule2: Under the condition that the product has regulatory approval, the product is market ready.",
      "Rule3: Either the product has regulatory approval or it passes the validation study.",
      "Rule4: If the product passes the validation study, then either it meets specifications or, given that the lab follows GMP protocols, if the batch passes the quality check, the product is safe for human use.",
      "Rule5: Whenever the product is market ready, either it meets specifications or, under the condition that the lab follows GMP protocols, if the batch passes the quality check, the product is safe for human use.",
      "Rule6: If the batch is scheduled for retest, then if the batch fails the final test, the batch does not require reprocessing.",
      "Rule7: If the product is packaged, then it is safe for human use.",
      "Rule8: Whenever the FDA approves the process, it is not the case that the company produces the compound.",
      "Rule9: Under the condition that the product is shipped, the product is safe for human use.",
      "Rule10: If the product is labeled correctly, then it is packaged.",
      "Rule11: Provided that the product is documented properly, the product is shipped.",
      "Rule12: If the quality manager authorizes release, then either the product is labeled correctly or it is documented properly.",
      "Rule13: If the supervisor approves, then if it is not the case that the quality manager authorizes release, the product is released.",
      "Rule14: Either the supervisor approves or the director approves.",
      "Rule15: Under the condition that the director approves, if it is not the case that the quality manager authorizes release, the product is released.",
      "Rule16: If the clinical trial for the drug is successful, then either the product meets specifications or, given that the lab follows GMP protocols, if the batch passes the quality check, the product is safe for human use.",
      "Rule17: If the company files the regulatory submission, then if it is not the case that the clinical trial for the drug is successful, Phase III for the drug is complete.",
      "Rule18: Either the patent is granted for the invention or the company files the regulatory submission.",
      "Rule19: Whenever the company files the patents, the company secures intellectual property.",
      "Rule20: Either the company files the patents or the formula is protected as a trade secret.",
      "Rule21: If the formula is protected as a trade secret, then it is not the case that the patent is granted for the invention.",
      "Rule22: If the warehouse manages inventory, then either the product is packaged or the product is shipped.",
      "Rule23: Either a recall is issued for the product or, if the supply chain is disrupted at the distributor, the product is available in stock.",
      "Rule24: If the material is pure, then it is sterile.",
      "Rule25: Under the condition that the material is sterile, it is not the case that the material is contaminated.",
      "Rule26: Either the batch passes the quality check or the batch fails the quality check.",
      "Rule27: Provided that the batch fails the quality check, the product is safe for human use.",
      "Rule28: If the lab uses sterile equipment, then if the batch passes the quality check, the product is safe for human use.",
      "Rule29: Either the lab uses sterile equipment or the lab follows GMP protocols.",
      "Rule30: If it is not the case that if the batch undergoes final testing then the product is safe for human use, then the batch requires reprocessing.",
      "Rule31: If it is not the case that if the batch undergoes final testing then the product is safe for human use, then the batch fails the final test.",
      "Rule32: If it is not the case that if the company secures intellectual property then the company has exclusive rights, then infringement occurs by the competitor.",
      "Rule33: Under the condition that it is not the case that if the company secures intellectual property then the company has exclusive rights, it is not the case that infringement occurs by the competitor.",
      "Rule34: If it is not the case that the batch is scheduled for retest, then the batch is discarded.",
      "Rule35: Whenever it is not the case that the batch is scheduled for retest, it is not the case that the batch is discarded.",
      "Rule36: If it is not the case that the FDA approves the process, then the material is contaminated.",
      "Rule37: Provided that it is not the case that the FDA approves the process, the material is pure.",
      "Rule38: Whenever it is not the case that the quality manager authorizes release, it is not the case that the product is released.",
      "Rule39: Provided that it is not the case that the clinical trial for the drug is successful, it is not the case that Phase III for the drug is complete.",
      "Rule40: If it is not the case that the warehouse manages inventory, then the supply chain is disrupted at the distributor."
    ],
    "facts": [
      "Fact1: The batch undergoes final testing.",
      "Fact2: It is not the case that the product meets specifications.",
      "Fact3: It is not the case that the company has exclusive rights.",
      "Fact4: It is not the case that the product is available in stock.",
      "Fact5: It is not the case that a recall is issued for the product."
    ]
  },
  "question": "The product is safe for human use."
}